Skip Main Navigation
Page Content

Panacea Innovation

Panacea Innovation (formerly Oxford Biotech) is an umbrella underneath which novel initiatives are introduced to mine for “undervalued assets” in the Academia/Industry/Investment triple-helix and give rise to high-impact assets, whenever and wherever.


Our mission is to change the way the world does science, for the betterment of humankind, by establishing vehicles that aim to maximize life and health sciences translation whilst providing outstanding revenues to our partners.


Panacea Innovation initiatives are broad ranging. From academia, where funding and credit for scientists and clinicians can be controlled by publishing lots of low- impact papers or speaking at conferences in a cycle that seems underperforming, to industry where the declining R&D productivity has raised doubts about the sustainability of its renowned financial returns, to venture capital where investors still need a better established deal flow rather than looking for the Nash equilibrium.

Sorry, there are no upcoming events

Save This Event

Event Saved